- POSITIVE
Quarterly Revenue Sudeep Pharma Sep-2026 Quarterly Revenue is Rs 148 Cr which is growth of 46.9% YoY.
- POSITIVE
Quarterly Net Profit Sudeep Pharma Sep-2026 Quarterly Net Profit is Rs 42 Cr which is growth of 42.4% YoY.
1217.5047.80(4.09%)
277.8K
NSE+BSE Volume
NSE 17 Nov, 2026 3:31 PM
Sudeep Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Sudeep Pharma quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|---|
| 147.9 | 115.5 | 89.8 | 99.7 | 100.7 | 86.8 | 108 | 85.8 | ||
Operating Exp. | 85.8 | 66.5 | 51.3 | 60.7 | 57 | 49.8 | 59.4 | 57 | |
Operating Profit | 51.6 | 39.2 | 28.9 | 29.6 | 30.9 | 30.4 | 45.5 | 26.5 | |
Operating Profit Margin % | 37.56% | 37.09% | 36.03% | 32.80% | 35.14% | 37.91% | 43.36% | 31.70% | |
Depr. | 3.1 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.7 | 1.5 | |
Interest | 2.3 | 1.8 | 2 | 0.6 | 2 | 1.4 | 1.6 | 1.3 | |
Profit Before Tax | 56.8 | 45.4 | 34.7 | 36.6 | 39.9 | 33.8 | 45.3 | 26 | |
Tax | 14.4 | 11.6 | 9 | 9.8 | 10.2 | 8.6 | 12.2 | 5.3 | |
Net Profit | 42.3 | 33.8 | 25.8 | 26.9 | 29.7 | 25.2 | 33.1 | 20.6 | |
EPS Adj. latest | 3.8 | 3 | 2.3 | 2.4 | 2.6 | 2.2 | 2.9 | 1.8 | |
Net profit TTM | 128.8 | 116.2 | 107.6 | 115 | 108.7 | - | - | - | |
Basic EPS TTM | 11.4 | 10.3 | 9.5 | 10.2 | 11.2 | - | - | - | |
Earnings Transcripts | |||||||||
Results PDF | |||||||||
Result Notes |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Sudeep Pharma competitor comparison and performance snapshot within industry
Sudeep Pharma revenue mix: sales, profit, and capital employed breakups by segment
Sudeep Pharma annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Annual Revenue Sudeep Pharma Mar-2026 Annual Revenue is Rs 377 Cr which is growth of 3.3% YoY.
- POSITIVE
Annual Net Profit Sudeep Pharma Mar-2026 Annual Net Profit is Rs 108 Cr which is growth of 12.4% YoY.
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
3.3%
2Y CAGR
3.5%
3Y CAGR
-3.2%
Net Profit Ann.
1Y CHG
12.3%
2Y CAGR
4.7%
3Y CAGR
17%
Operating Exp. Ann.
1Y CHG
-2.7%
2Y CAGR
1.7%
3Y CAGR
-11.5%
Sudeep Pharma balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Sudeep Pharma Mar-2026 Total Shareholders Fund is Rs 786 Cr which is growth of 82.7% YoY.
- POSITIVE
Total Assets Sudeep Pharma Mar-2026 Total Assets is Rs 974 Cr which is growth of 61.2% YoY.
| Indicator | Graph | CAGR 3 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 |
|---|---|---|---|---|---|---|
49.1% | 786 | 430.1 | 334.6 | 236.9 | ||
Minority Interest Liability Ann. | - | - | - | - | - | |
40.5% | 42.7 | 40.9 | 11.5 | 15.4 | ||
-3.9% | 145.1 | 130.8 | 104.5 | 163.7 | ||
Total Capital Plus Liabilities Ann. | 32.8% | 973.8 | 604.1 | 450.6 | 416 | |
31.6% | 263 | 193 | 139.4 | 115.4 | ||
42% | 515.8 | 291.1 | 219.9 | 180.2 | ||
24.8% | 458 | 313 | 230.8 | 235.9 | ||
Total Assets Ann. | 32.8% | 973.8 | 604.1 | 450.6 | 416 | |
Contingent Liabilities plus Commitments Ann. | -20.3% | 7.2 | 127.4 | 19.8 | 14.2 | |
Bonus Equity Share Capital Ann. | - | 0.8 | 0.8 | |||
Non Current Investments Unquoted Book Value Ann. | 26.9% | 32.1 | 31.4 | 28.6 | 15.7 | |
Current Investments Unquoted Book Value Ann. | - |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Assets Ann.
1Y CHG
61.2%
2Y CAGR
47%
3Y CAGR
32.8%
Total Current Liabilities Ann.
1Y CHG
10.9%
2Y CAGR
17.8%
3Y CAGR
-3.9%
Total ShareHolders Funds Ann.
1Y CHG
82.7%
2Y CAGR
53.3%
3Y CAGR
49.1%
Sudeep Pharma ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Book Value Per Share Sudeep Pharma Mar-2026 Book Value Per Share is 70 Rs which is growth of 58.1% YoY.
- POSITIVE
ROE Sudeep Pharma Mar-2026 ROE is 14% which is growth of 8.7% YoY.
| Indicator | Graph | CAGR 3 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 |
|---|---|---|---|---|---|---|
BVSH Ann. | -65.4% | 69.6 | 44 | 2,374.6 | 1,681.1 | |
RoA Ann. % | -11.9% | 11.04% | 15.84% | 21.76% | 16.14% | |
ROE Ann. % | -21.6% | 13.68% | 22.37% | 29.31% | 28.35% | |
ROCE Ann. % | -21.3% | 18.24% | 28.35% | 39.08% | 37.49% | |
- | ||||||
- | ||||||
- | ||||||
Total Debt to Total Equity Ann. | -12.6% | 0.2 | 0.3 | 0.2 | 0.3 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
ROE Ann. %
1Y CHG
-38.8%
2Y CAGR
-31.7%
3Y CAGR
-21.6%
RoA Ann. %
1Y CHG
-30.3%
2Y CAGR
-28.8%
3Y CAGR
-11.9%
Current Ratio Ann.
1Y CHG
33.3%
2Y CAGR
20.6%
3Y CAGR
31.7%
Sudeep Pharma cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Cash From Operating Activity Sudeep Pharma Mar-2026 Cash From Operating Activity is Rs 96 Cr which is growth of 62.3% YoY.
- NEGATIVE
Net Cash Flow Sudeep Pharma Mar-2026 Net Cash Flow is Rs -28 Cr which is growth of -229.5% YoY.
| Indicator | Graph | CAGR 3 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 |
|---|---|---|---|---|---|---|
31.4% | 96 | 59.2 | 59.1 | 42.3 | ||
Cash from Investing Act. Ann. | - | -366.7 | -91.6 | -40.7 | -40.7 | |
Cash from Financing Act. Ann. | - | 242.5 | 54.2 | -16.1 | -10.1 | |
- | -28.2 | 21.8 | 2.2 | -8.5 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
62.2%
2Y CAGR
27.5%
3Y CAGR
31.4%
Cash from Financing Act. Ann.
1Y CHG
347.4%
